NO20022984L - Forbindelse og fremgangsmåte for behandling av smerte - Google Patents

Forbindelse og fremgangsmåte for behandling av smerte

Info

Publication number
NO20022984L
NO20022984L NO20022984A NO20022984A NO20022984L NO 20022984 L NO20022984 L NO 20022984L NO 20022984 A NO20022984 A NO 20022984A NO 20022984 A NO20022984 A NO 20022984A NO 20022984 L NO20022984 L NO 20022984L
Authority
NO
Norway
Prior art keywords
compound
treating pain
pain
treating
Prior art date
Application number
NO20022984A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022984D0 (no
Inventor
Thomas Michael Bare
Dean Gordon Brown
Megan Murphy
Rebecca Ann Urbanek
Wenhua Xiao
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20022984D0 publication Critical patent/NO20022984D0/no
Publication of NO20022984L publication Critical patent/NO20022984L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20022984A 1999-12-23 2002-06-20 Forbindelse og fremgangsmåte for behandling av smerte NO20022984L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17190699P 1999-12-23 1999-12-23
US23678300P 2000-09-29 2000-09-29
PCT/SE2000/002611 WO2001047927A1 (en) 1999-12-23 2000-12-19 Compound and method for the treatment of pain

Publications (2)

Publication Number Publication Date
NO20022984D0 NO20022984D0 (no) 2002-06-20
NO20022984L true NO20022984L (no) 2002-08-20

Family

ID=26867555

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022984A NO20022984L (no) 1999-12-23 2002-06-20 Forbindelse og fremgangsmåte for behandling av smerte

Country Status (29)

Country Link
EP (1) EP1244662B1 (de)
JP (1) JP2003519149A (de)
KR (1) KR20020062369A (de)
CN (1) CN1188413C (de)
AR (1) AR027037A1 (de)
AT (1) ATE294177T1 (de)
AU (1) AU779703B2 (de)
BG (1) BG106831A (de)
BR (1) BR0016654A (de)
CA (1) CA2394888A1 (de)
CO (1) CO5271689A1 (de)
CZ (1) CZ296877B6 (de)
DE (1) DE60019807T2 (de)
DK (1) DK1244662T3 (de)
EE (1) EE200200350A (de)
ES (1) ES2239632T3 (de)
HK (1) HK1048811B (de)
HU (1) HUP0300313A3 (de)
IL (1) IL150208A0 (de)
IS (1) IS6427A (de)
MX (1) MXPA02006155A (de)
MY (1) MY133596A (de)
NO (1) NO20022984L (de)
NZ (1) NZ519390A (de)
PL (1) PL356664A1 (de)
PT (1) PT1244662E (de)
RU (1) RU2234507C2 (de)
SK (1) SK8792002A3 (de)
WO (1) WO2001047927A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0403172D0 (sv) * 2004-12-23 2004-12-23 Astrazeneca Ab Manufacturing process
US20060280791A1 (en) * 2005-04-08 2006-12-14 Ju Tzuchi R Pharmaceutical formulations
JP5790533B2 (ja) * 2012-02-14 2015-10-07 住友化学株式会社 フェニルヒドラジン−β−カルボキシレート化合物の精製方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111266A (en) * 1993-10-22 2002-03-10 Zeneca Ltd 2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
AR027037A1 (es) 2003-03-12
ATE294177T1 (de) 2005-05-15
IS6427A (is) 2002-06-19
HK1048811A1 (en) 2003-04-17
AU779703B2 (en) 2005-02-10
EP1244662B1 (de) 2005-04-27
ES2239632T3 (es) 2005-10-01
SK8792002A3 (en) 2003-05-02
KR20020062369A (ko) 2002-07-25
WO2001047927A1 (en) 2001-07-05
DK1244662T3 (da) 2005-07-11
PT1244662E (pt) 2005-07-29
NO20022984D0 (no) 2002-06-20
EP1244662A1 (de) 2002-10-02
RU2234507C2 (ru) 2004-08-20
BR0016654A (pt) 2002-09-03
HK1048811B (zh) 2005-09-30
AU2420301A (en) 2001-07-09
CZ20022177A3 (cs) 2002-11-13
MXPA02006155A (es) 2002-12-05
EE200200350A (et) 2003-10-15
CN1411459A (zh) 2003-04-16
CA2394888A1 (en) 2001-07-05
IL150208A0 (en) 2002-12-01
PL356664A1 (en) 2004-06-28
JP2003519149A (ja) 2003-06-17
CO5271689A1 (es) 2003-04-30
HUP0300313A2 (hu) 2003-06-28
HUP0300313A3 (en) 2007-05-02
MY133596A (en) 2007-11-30
CZ296877B6 (cs) 2006-07-12
DE60019807T2 (de) 2006-01-19
NZ519390A (en) 2003-07-25
DE60019807D1 (de) 2005-06-02
CN1188413C (zh) 2005-02-09
BG106831A (en) 2003-03-31

Similar Documents

Publication Publication Date Title
GB2351661B (en) Novel method of treatment
IL145875A0 (en) Novel method of treatment
NO20010117D0 (no) Fremgangsmåte for behandling av sövnlöshet
NO985484D0 (no) FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi
DE60016423D1 (de) Ätzmethode und plasmabehandlungsmethode
NO20022984L (no) Forbindelse og fremgangsmåte for behandling av smerte
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte
GB9930688D0 (en) Novel method of treatment
NO20006383L (no) Fremgangsmåte for behandling
NO20022157D0 (no) Fremgangsmåte for behandling av medikamentavhengighet
FI990520A0 (fi) Menetelmä ja laitteisto nollaveden käsittelemiseksi
UA36394A (uk) Спосіб лікування обтураційної жовтяниці
UA34051A (uk) Спосіб лікування аскоферозу бджіл
UA25504A (uk) Спосіб лікуваhhя дисбактеріозу hосоглотки
GB9930696D0 (en) Novel method of treatment
GB9822681D0 (en) Method of treatment
GB9915597D0 (en) Method of treatment
GB9903950D0 (en) Method of treatment
TJ99000556A (en) Method of treatment of nevrodermite
UA33970A (uk) Спосіб лікування періодонтиту
ID27244A (id) Metode untuk memperlakukan satu gas
TJ99000555A (en) Method of treatment of psoriasis
EE9800006A (et) Jäätmete töötlemise meetod
GB9930690D0 (en) Novel method of treatment
GB9930692D0 (en) Novel method of treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application